• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number M0068505110
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Fatigue (1849); Headache (1880); Incontinence (1928); Muscular Rigidity (1968); Pain (1994); Pneumonia (2011); Blurred Vision (2137); Injury (2348); Disability (2371); Cognitive Changes (2551); No Code Available (3191)
Event Date 05/31/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Other: tga device incident report reference no (b)(4); submitted to tga (therapeutic goods administration) by a healthcare professional/user.The complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an obtryx ii system - halo was implanted into the patient during a procedure performed on (b)(6) 2016.According to the complainant, following the implantation, the patient experienced chest pains, hospitalization, multiple pneumonia and pleurisy (no bacteria detected), chronic productive cough leading to upper respiratory dysfunction, chronic back and buttocks pain and bladder leakage while walking.The patient also experienced autoimmune symptoms including chronic fatigue, joint pain and stiffness, vision disturbance, memory loss, headaches, and passing out.The patient initially needed to reduce working hours to 3 hours a day but eventually has to permanently leave job.Subsequently, the patient underwent mesh removal on (b)(6) 2018.Boston scientific has been unable to obtain additional information regarding the event to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBTRYX II SYSTEM - HALO
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
FREUDENBERG MEDICAL MIS INC
2301 centennial boulevard
jeffersonville IN 47130
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key10892863
MDR Text Key217958814
Report Number3005099803-2020-05649
Device Sequence Number1
Product Code OTN
UDI-Device Identifier08714729837565
UDI-Public08714729837565
Combination Product (y/n)N
PMA/PMN Number
K121754
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial
Report Date 11/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/12/2019
Device Model NumberM0068505110
Device Catalogue Number850-511
Device Lot Number0000045394
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/31/2018
Initial Date FDA Received11/24/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/12/2016
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-